The catalytic activity enables NanoICD/CAT to decompose H2O2 (Fig. 5C) and generate O2 effectively (Fig. 5D), thus providing the potential to alleviate tumor hypoxia and remodel immunosuppressive TME to enhance cancer immunotherapy. Here, CAT is linked to neoplasm.